AETHLON MEDICAL INC AEMD
AETHLON MEDICAL INC financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $574,245 | $294,165 | $659,104 | $650,187 | $229,625 | $149,625 | $392,073 |
| R&D expense | $1.9M | $2.2M | $2.5M | $2.7M | $2.3M | $2.1M | $927,000 | $896,000 | $586,000 | $673,000 |
| Operating income | -$7.3M | -$9.3M | -$12.6M | -$11.9M | -$10.4M | -$7.9M | -$5.9M | -$6.0M | -$4.8M | -$6.1M |
| Interest expense | — | $10,109 | — | — | — | — | — | — | — | — |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$7.2M | -$13.4M | -$12.2M | -$12.0M | -$10.4M | -$7.9M | -$6.4M | -$6.2M | -$5.7M | -$7.3M |
| EPS (diluted) | $-10.61 | $-85.77 | $-38.87 | $-5.86 | $-0.71 | — | — | — | — | — |
| Operating cash flow | -$7.0M | -$7.6M | -$10.1M | -$10.5M | -$9.8M | -$6.8M | -$5.2M | -$4.3M | -$3.9M | -$3.5M |
| Free cash flow | -$7.0M | -$7.6M | -$10.4M | -$11.4M | -$10.1M | -$6.8M | -$5.3M | -$4.3M | -$3.9M | -$3.5M |
| Cash & equivalents | $5.0M | $5.5M | $5.4M | $14.5M | $17.1M | $9.9M | $9.6M | — | — | — |
| Total assets | $6.3M | $7.4M | $8.2M | $17.5M | $19.4M | $10.7M | $10.4M | $4.1M | $7.4M | $1.7M |
| Total liabilities | $1.4M | $2.2M | $2.5M | $2.4M | $2.4M | $1.4M | $1.1M | $1.8M | $1.3M | $1.1M |
| Shareholders' equity | $4.9M | $5.1M | $5.8M | $15.1M | $17.0M | $9.4M | $9.4M | $2.4M | $6.1M | $676,379 |
Growth · year-over-year
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | -100.0% | +95.2% | -55.4% | +1.4% | +183.2% | +53.5% | -61.8% | -55.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.